Pyxis Oncology announces updated data from its Phase 1 study of micvotabart pelidotin for cancer treatment, showcasing advancements in pharmaceutical preparations.
| Name | Pyxis Oncology, Inc. |
|---|---|
| CIK | 0001782223 |
| Tickers | PYXS |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | <br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 831160910 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (617) 221-9059 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Pyxis Oncology announces updated data from its Phase 1 study of micvotabart pelidotin for cancer treatment, showcasing advancements in pharmaceutical preparations.
Pyxis Oncology, Inc. has approved an increase in its authorized shares from 190 million to 380 million, enhancing its capital-raising capabilities.
Rachel Humphrey, director at Pyxis Oncology, exercises stock option for 34,500 shares, signaling confidence in the company's future.
Pyxis Oncology, Inc. shares its Q3 results, emphasizing growth strategies and ongoing innovations in the pharmaceutical preparations sector.
Pyxis Oncology, Inc. announces its financial results for Q3 2026, highlighting key operational updates and future directions.
Laurion Capital Management has reported owning over 5% of Pyxis Oncology, indicating significant interest in the pharmaceutical sector.
Pyxis Oncology announces a special meeting to discuss increasing authorized shares, reflecting growth plans in the pharmaceutical preparations sector.
362 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | 8-K | 8-K | 7.01,8.01 | 0001193125-26-467780 | 001-40881 | 261572287 | 34 | 15443729 | 1 | 1 |
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000947871-26-001035 | 005-92951 | 261563355 | 34 | 14790 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-003186 | 005-92951 | 261561421 | 34 | 29117 | |||
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493215-26-000202 | 005-92951 | 261555702 | 34 | 13275 | |||
| 2026-11-13 | 8-K | 8-K | 5.03,5.07 | 0001193125-26-460698 | 001-40881 | 261552787 | 34 | 201804 | 1 | 1 |
| 2026-11-06 | 4 | 4 | 0001193125-26-452175 | 5427 | ||||||
| 2026-11-05 | 10-Q | 10-Q | 0001193125-26-448612 | 001-40881 | 261524851 | 34 | 13163639 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02 | 0001193125-26-448604 | 001-40881 | 261524841 | 34 | 495694 | 1 | 1 |
| 2026-11-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001390202-26-000019 | 005-92951 | 261514629 | 34 | 11418 | |||
| 2026-10-21 | DEF 14A | DEF 14A | 0001193125-26-427882 | 001-40881 | 261475998 | 34 | 851718 | |||
| 2026-10-09 | PRE 14A | PRE 14A | 0001193125-26-419208 | 001-40881 | 261453634 | 34 | 803868 | |||
| 2026-10-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-006818 | 005-92951 | 261452487 | 34 | 21387 | |||
| 2026-10-09 | 4/A | xslF345X06/ownership.xml | 0000919574-26-006815 | 13444 | ||||||
| 2026-10-05 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-113597 | 005-92951 | 261439172 | 34 | 25231 | |||
| 2026-10-02 | 4 | xslF345X06/ownership.xml | 0000919574-26-006609 | 14891 | ||||||
| 2026-10-02 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-006608 | 005-92951 | 261433526 | 34 | 24212 | |||
| 2026-10-01 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001437749-26-031767 | 001-40881 | 261432587 | 34 | 828113 | 1 | 1 |
| 2026-10-01 | 424B5 | FORM 424B5 | 0001437749-26-031667 | 333-291801 | 261429217 | 33 | 747634 | |||
| 2026-09-29 | 424B5 | FORM 424B5 | 0001437749-26-031480 | 333-291801 | 261424586 | 33 | 756487 | |||
| 2026-09-29 | 424B5 | FORM 424B5 | 0001437749-26-031470 | 333-291801 | 261424066 | 33 | 14025 | |||
| 2026-09-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-385901 | 001-40881 | 261366682 | 34 | 18030921 | 1 | 1 |
| 2026-09-08 | 4 | 4 | 0001193125-26-384391 | 5573 | ||||||
| 2026-09-08 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-26-384386 | 001-40881 | 261363398 | 34 | 266167 | 1 | 1 |
| 2026-08-28 | 424B2 | 424B2 | 0001193125-26-372221 | 333-298461 | 261332923 | 33 | 319912 | |||
| 2026-08-27 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002786 | 333-298461 | 261332655 | 33 | 1700 | ||
| 2026-08-20 | 4 | 4 | 0001193125-26-359525 | 5407 | ||||||
| 2026-08-20 | S-3 | S-3 | 0001193125-26-359246 | 333-298461 | 261300256 | 33 | 724828 | 1 | 1 | |
| 2026-08-14 | 4 | 4 | 0001193125-26-352206 | 5794 | ||||||
| 2026-08-13 | 10-Q | 10-Q | 0001193125-26-347913 | 001-40881 | 261270094 | 34 | 9877532 | 1 | 1 | |
| 2026-08-13 | 8-K | 8-K | 2.02 | 0001193125-26-347911 | 001-40881 | 261270093 | 34 | 492627 | 1 | 1 |
| 2026-07-10 | 3 | xslF345X06/ownership.xml | 0000919574-26-004386 | 11799 | ||||||
| 2026-07-10 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-001796 | 005-92951 | 261168809 | 34 | 40334 | |||
| 2026-07-02 | 4 | 4 | 0001193125-26-294708 | 9254 | ||||||
| 2026-07-02 | 8-K | 8-K | 1.01,3.02,7.01 | 0001193125-26-294613 | 001-40881 | 261151601 | 34 | 1267736 | 1 | 1 |
| 2026-07-02 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-004255 | 005-92951 | 261151235 | 34 | 19985 | |||
| 2026-06-30 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004977 | 001-40881 | 261140652 | 33 | 4335 | |||
| 2026-06-15 | 8-K | 8-K | 5.07 | 0001193125-26-271137 | 001-40881 | 261091141 | 34 | 171005 | 1 | 1 |
| 2026-05-14 | 10-Q | 10-Q | 0001193125-26-222843 | 001-40881 | 26975903 | 34 | 9722271 | 1 | 1 | |
| 2026-05-14 | 8-K | 8-K | 2.02 | 0001193125-26-222818 | 001-40881 | 26975873 | 34 | 446555 | 1 | 1 |
| 2026-04-30 | ARS | ARS | 0001193125-26-194065 | 001-40881 | 26920131 | 34 | 12060769 | |||
| 2026-04-30 | DEFA14A | DEFA14A | 0001193125-26-194051 | 001-40881 | 26920119 | 34 | 2215788 | |||
| 2026-04-30 | DEF 14A | DEF 14A | 0001193125-26-194032 | 001-40881 | 26920112 | 34 | 1820362 | |||
| 2026-04-30 | 8-K/A | 8-K/A | 5.02 | 0001193125-26-193940 | 001-40881 | 26920015 | 34 | 160122 | 1 | 1 |
| 2026-03-25 | 4 | 4 | 0001193125-26-124388 | 5399 | ||||||
| 2026-03-25 | 4 | 4 | 0001193125-26-124380 | 7310 | ||||||
| 2026-03-25 | 4 | 4 | 0001193125-26-124348 | 5393 | ||||||
| 2026-03-25 | 4 | 4 | 0001193125-26-124342 | 5407 | ||||||
| 2026-03-25 | 4 | 4 | 0001193125-26-124333 | 5416 | ||||||
| 2026-03-25 | 4 | 4 | 0001193125-26-124325 | 5442 | ||||||
| 2026-03-25 | 4 | 4 | 0001193125-26-124319 | 5418 | ||||||
| 2026-03-25 | 4 | 4 | 0001193125-26-124313 | 5408 | ||||||
| 2026-03-25 | 4 | FORM 4 | 0000905148-26-001434 | 8427 | ||||||
| 2026-03-23 | S-8 | S-8 | 0001193125-26-119700 | 333-294526 | 26782180 | 33 | 388852 | 1 | 1 | |
| 2026-03-23 | 10-K | 10-K | 0001193125-26-118532 | 001-40881 | 26779884 | 34 | 74373211 | 1 | 1 | |
| 2026-03-23 | 8-K | 8-K | 2.02,7.01 | 0001193125-26-118525 | 001-40881 | 26779876 | 34 | 22082402 | 1 | 1 |
| 2026-02-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001390202-26-000002 | 005-92951 | 26610241 | 34 | 11502 | |||
| 2026-02-06 | 8-K | 8-K | 9.01 | 0001193125-26-041169 | 001-40881 | 26607648 | 34 | 197883 | 1 | 1 |
| 2026-02-05 | 4 | 4 | 0001193125-26-039951 | 5301 | ||||||
| 2025-12-18 | 8-K | 8-K | 7.01,8.01 | 0001193125-25-323704 | 001-40881 | 251581270 | 34 | 15447346 | 1 | 1 |
| 2025-12-09 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003615 | 333-291801 | 251560742 | 33 | 1700 | ||
| 2025-12-08 | CORRESP | filename1.htm | 0001437749-25-037150 | 8499 | ||||||
| 2025-11-26 | S-3 | FORM S-3 | 0001437749-25-036389 | 333-291801 | 251524790 | 33 | 1792812 | 1 | 1 | |
| 2025-11-03 | 10-Q | 10-Q | 0001193125-25-261696 | 001-40881 | 251442132 | 34 | 10111421 | 1 | 1 | |
| 2025-11-03 | 8-K | 8-K | 2.02 | 0001193125-25-261689 | 001-40881 | 251442125 | 34 | 18625671 | 1 | 1 |
| 2025-10-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-099264 | 005-92951 | 251391752 | 34 | 15867 | |||
| 2025-09-23 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-005781 | 005-92951 | 251332838 | 34 | 20383 | |||
| 2025-08-14 | 10-Q | 10-Q | 0000950170-25-108906 | 001-40881 | 251219552 | 34 | 12374515 | 1 | 1 | |
| 2025-08-14 | 8-K | 8-K | 2.02 | 0000950170-25-108898 | 001-40881 | 251219479 | 34 | 18621674 | 1 | 1 |
| 2025-08-04 | 8-K | 8-K | 8.01 | 0000950170-25-101618 | 001-40881 | 251177995 | 34 | 156858 | 1 | 1 |
| 2025-07-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-003255 | 005-92951 | 251132433 | 34 | 10706 | |||
| 2025-07-03 | 8-K | 8-K | 5.02 | 0000950170-25-093456 | 001-40881 | 251103476 | 34 | 158500 | 1 | 1 |
| 2025-07-01 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-064765 | 005-92951 | 251096952 | 34 | 15489 | |||
| 2025-06-18 | 8-K | 8-K | 5.07 | 0000950170-25-087907 | 001-40881 | 251057193 | 34 | 172606 | 1 | 1 |
| 2025-05-15 | 10-Q | 10-Q | 0000950170-25-071996 | 001-40881 | 25948744 | 34 | 9665916 | 1 | 1 | |
| 2025-05-15 | 8-K | 8-K | 2.02,7.01 | 0000950170-25-071992 | 001-40881 | 25948730 | 34 | 18589460 | 1 | 1 |
| 2025-05-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-045055 | 005-92951 | 25917512 | 34 | 18542 | |||
| 2025-04-29 | DEFA14A | DEFA14A | 0000950170-25-059575 | 001-40881 | 25882702 | 34 | 778657 | |||
| 2025-04-29 | DEF 14A | DEF 14A | 0000950170-25-059573 | 001-40881 | 25882701 | 34 | 3105802 | |||
| 2025-04-21 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-002656 | 001-40881 | 25853315 | 33 | 5535 | |||
| 2025-04-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-002643 | 001-40881 | 25847672 | 33 | 4956 | |||
| 2025-04-14 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-002600 | 001-40881 | 25836072 | 33 | 4363 | |||
| 2025-04-02 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-25-049860 | 005-92951 | 25807236 | 34 | 9607 | |||
| 2025-04-02 | 4 | 4 | 0000950170-25-048905 | 5443 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-048903 | 5217 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-048902 | 5450 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-048901 | 5286 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-048900 | 5284 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-048899 | 5221 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-048898 | 5264 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-048895 | 5215 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-048894 | 5254 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-048893 | 5457 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-048892 | 5258 | ||||||
| 2025-03-24 | 8-K | 8-K | 7.01,9.01 | 0000950170-25-043491 | 001-40881 | 25762228 | 34 | 17095594 | 1 | 1 |
| 2025-03-18 | S-8 | S-8 | 0000950170-25-041315 | 333-285889 | 25749160 | 33 | 242244 | |||
| 2025-03-18 | 10-K | 10-K | 0000950170-25-040771 | 001-40881 | 25746533 | 34 | 40983567 | 1 | 1 | |
| 2025-03-18 | 8-K | 8-K | 2.02,5.02,7.01,9.01 | 0000950170-25-040767 | 001-40881 | 25746512 | 34 | 17345972 | 1 | 1 |
| 2025-02-26 | 8-K | 8-K | 8.01 | 0000950170-25-027330 | 001-40881 | 25666170 | 34 | 232138 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-014027 | 005-92951 | 25628069 | 34 | 11400 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-000884 | 005-92951 | 25623563 | 34 | 11211 | |||
| 2025-02-04 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-000665 | 005-92951 | 25587832 | 34 | 11611 | |||
| 2025-02-04 | 8-K | 8-K | 8.01 | 0000950170-25-012846 | 001-40881 | 25585364 | 34 | 237485 | 1 | 1 |
| 2024-12-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-24-139789 | 005-92951 | 241575213 | 34 | 8520 | |||
| 2024-12-23 | 4 | 4 | 0000950170-24-139616 | 5319 | ||||||
| 2024-12-23 | 4 | 4 | 0000950170-24-139608 | 5328 | ||||||
| 2024-12-23 | 4 | 4 | 0000950170-24-139598 | 5324 | ||||||
| 2024-12-19 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-138563 | 001-40881 | 241564124 | 34 | 260784 | 1 | 1 |
| 2024-12-16 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-24-128889 | 005-92951 | 241551777 | 34 | 19884 | |||
| 2024-11-27 | 4 | 4 | 0000950170-24-131606 | 6850 | ||||||
| 2024-11-20 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-129238 | 001-40881 | 241480356 | 34 | 21366604 | 1 | 1 |
| 2024-11-12 | S-8 | S-8 | 0000950170-24-125555 | 333-283161 | 241449121 | 33 | 199320 | |||
| 2024-11-12 | SC 13G/A | LAURION CAPITAL MANAGEMENT LP | 0001085146-24-005529 | 005-92951 | 241445821 | 34 | 46157 | |||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-124602 | 001-40881 | 241443372 | 34 | 7984192 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02 | 0000950170-24-124581 | 001-40881 | 241443335 | 34 | 374762 | 1 | 1 |
| 2024-11-06 | SC 13G/A | SC 13G/A | 0001104659-24-114823 | 005-92951 | 241431643 | 34 | 57436 | |||
| 2024-10-23 | 8-K | 8-K | 5.07,9.01 | 0000950170-24-116698 | 001-40881 | 241389681 | 34 | 173917 | 1 | 1 |
| 2024-09-25 | DEF 14A | DEF 14A | 0000950170-24-109337 | 001-40881 | 241324178 | 34 | 3155267 | |||
| 2024-09-13 | PRE 14A | PRE 14A | 0000950170-24-106381 | 001-40881 | 241298103 | 34 | 1265581 | |||
| 2024-08-14 | 10-Q | 10-Q | 0000950170-24-097073 | 001-40881 | 241208423 | 34 | 7791960 | 1 | 1 | |
| 2024-08-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-097054 | 001-40881 | 241208257 | 34 | 361585 | 1 | 1 |
| 2024-06-12 | 8-K | 8-K | 5.07 | 0000950170-24-072467 | 001-40881 | 241038620 | 34 | 177867 | 1 | 1 |
| 2024-06-10 | 4 | 4 | 0000950170-24-071438 | 5262 | ||||||
| 2024-06-10 | 3 | 3 | 0000950170-24-071435 | 25252 | ||||||
| 2024-06-10 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-24-157911 | 001-40881 | 241031490 | 34 | 175898 | 1 | 1 |
| 2024-06-07 | 4 | 4 | 0000950170-24-070833 | 4618 | ||||||
| 2024-05-14 | 10-Q | 10-Q | 0000950170-24-059099 | 001-40881 | 24941503 | 34 | 7066073 | 1 | 1 | |
| 2024-05-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-059093 | 001-40881 | 24941494 | 34 | 2022161 | 1 | 1 |
| 2024-04-26 | ARS | ARS | 0000950170-24-049163 | 001-40881 | 24884016 | 34 | 7512275 | |||
| 2024-04-26 | DEFA14A | DEFA14A | 0000950170-24-049161 | 001-40881 | 24883993 | 34 | 2332146 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0000950170-24-049154 | 001-40881 | 24883973 | 34 | 3632813 | |||
| 2024-04-04 | 424B2 | FORM 424B2 | 0001437749-24-010967 | 333-278282 | 24821251 | 33 | 176179 | |||
| 2024-04-03 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-04-03 16:00:00 | 9999999995-24-000851 | 333-278282 | 24821528 | 33 | 1706 | ||
| 2024-04-03 | SC 13D/A | SC 13D/A | 0000950170-24-041264 | 005-92951 | 24819950 | 34 | 59552 | |||
| 2024-04-01 | CORRESP | filename1.htm | 0000950170-24-039387 | 16409 | ||||||
| 2024-03-29 | UPLOAD | filename1.pdf | 0000000000-24-003389 | 333-278282 | 40226 | |||||
| 2024-03-28 | 4 | 4 | 0000950170-24-038108 | 4829 | ||||||
| 2024-03-28 | 4 | 4 | 0000950170-24-038106 | 5455 | ||||||
| 2024-03-28 | 4 | 4 | 0000950170-24-038104 | 4663 | ||||||
| 2024-03-28 | 4 | 4 | 0000950170-24-038105 | 4626 | ||||||
| 2024-03-28 | 4 | 4 | 0000950170-24-038103 | 4686 | ||||||
| 2024-03-28 | 4 | 4 | 0000950170-24-038102 | 4668 | ||||||
| 2024-03-28 | 4 | 4 | 0000950170-24-038099 | 4687 | ||||||
| 2024-03-28 | 4 | 4 | 0000950170-24-038098 | 5261 | ||||||
| 2024-03-28 | 4 | 4 | 0000950170-24-038097 | 4824 | ||||||
| 2024-03-27 | S-3 | FORM S-3 | 0001437749-24-009629 | 333-278282 | 24791785 | 33 | 373749 | |||
| 2024-03-27 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-037176 | 001-40881 | 24790698 | 34 | 348368 | 1 | 1 |
| 2024-03-27 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-036822 | 001-40881 | 24785813 | 34 | 188093 | 1 | 1 |
| 2024-03-22 | S-8 | S-8 | 0000950170-24-034898 | 333-278159 | 24772539 | 33 | 203526 | |||
| 2024-03-21 | 10-K | 10-K | 0000950170-24-034868 | 001-40881 | 24772273 | 34 | 17879956 | 1 | 1 | |
| 2024-03-21 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-034427 | 001-40881 | 24769474 | 34 | 21819110 | 1 | 1 |
| 2024-03-13 | 4 | 4 | 0000950170-24-030865 | 5260 | ||||||
| 2024-03-13 | 3 | 3 | 0000950170-24-030842 | 16263 | ||||||
| 2024-03-13 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-24-030817 | 001-40881 | 24746380 | 34 | 190761 | 1 | 1 |
| 2024-03-08 | SC 13G | deeptrack-pyxs022724.htm | 0001172661-24-001677 | 005-92951 | 24734251 | 34 | 102901 | |||
| 2024-02-28 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0000950170-24-021643 | 001-40881 | 24690127 | 34 | 1191870 | 1 | 1 |
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 2 | 0001214659-24-002875 | 005-92951 | 24637364 | 34 | 83334 | |||
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0000921895-24-000436 | 005-92951 | 24633103 | 34 | 266012 | |||
| 2024-01-26 | SC 13G | SC 13G | 0001104659-24-007297 | 005-92951 | 24568435 | 34 | 81101 | |||
| 2023-12-29 | 4 | FORM 4 SUBMISSION | 0001209191-23-060006 | 7901 | ||||||
| 2023-12-06 | 3 | FORM 3 SUBMISSION | 0001209191-23-057631 | 6645 | ||||||
| 2023-11-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-056969 | 4745 | ||||||
| 2023-11-28 | 8-K | 8-K | 5.02,9.01 | 0000950170-23-066245 | 001-40881 | 231441892 | 34 | 332435 | 1 | 1 |
| 2023-11-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-055744 | 4795 | ||||||
| 2023-11-07 | 10-Q | 10-Q | 0000950170-23-060354 | 001-40881 | 231384750 | 34 | 9872282 | 1 | 1 | |
| 2023-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-060352 | 001-40881 | 231384699 | 34 | 412515 | 1 | 1 |
| 2023-10-27 | 8-K/A | 8-K/A | 9.01 | 0000950170-23-056026 | 001-40881 | 231356005 | 34 | 4054733 | 1 | 1 |
| 2023-09-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-050734 | 4760 | ||||||
| 2023-09-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-050686 | 4753 | ||||||
| 2023-09-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-050685 | 5088 | ||||||
| 2023-09-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-050613 | 5367 | ||||||
| 2023-09-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-050495 | 4753 | ||||||
| 2023-09-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-050492 | 5090 | ||||||
| 2023-09-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-050433 | 4757 | ||||||
| 2023-09-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-050432 | 4762 | ||||||
| 2023-09-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-049826 | 6072 | ||||||
| 2023-09-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-003986 | 001-40881 | 231261476 | 33 | 6552 | |||
| 2023-09-14 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-003945 | 001-40881 | 231255618 | 33 | 5968 | |||
| 2023-09-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-049366 | 10421 | ||||||
| 2023-09-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-003923 | 001-40881 | 231253224 | 33 | 5390 | |||
| 2023-09-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-003903 | 001-40881 | 231250567 | 33 | 4819 | |||
| 2023-09-11 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-003883 | 001-40881 | 231248289 | 33 | 4234 | |||
| 2023-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-048819 | 4705 | ||||||
| 2023-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-048816 | 4697 | ||||||
| 2023-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-048814 | 4691 | ||||||
| 2023-09-06 | UPLOAD | filename1.pdf | 0000000000-23-009852 | 39648 | ||||||
| 2023-09-05 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-003756 | 001-40881 | 231236800 | 33 | 9920 | |||
| 2023-08-28 | CORRESP | filename1.htm | 0000950170-23-044862 | 51853 | ||||||
| 2023-08-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-047384 | 10641 | ||||||
| 2023-08-25 | 3 | FORM 3 SUBMISSION | 0001209191-23-047383 | 6592 | ||||||
| 2023-08-24 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001437749-23-024546,2023-08-24 | 9999999995-23-002487 | 333-272510 | 231203717 | 33 | 1671 | ||
| 2023-08-23 | S-8 POS | FORM S-8 POS | 0001437749-23-024548 | 333-272510 | 231198433 | 33 | 409132 | |||
| 2023-08-23 | POS AM | FORM POS AM | 0001437749-23-024546 | 333-272510 | 231198414 | 33 | 913815 | |||
| 2023-08-23 | S-8 | FORM S-8 | 0001437749-23-024545 | 333-274178 | 231198412 | 33 | 225176 | |||
| 2023-08-23 | 8-K | 8-K | 2.01,5.02,7.01,9.01 | 0000950170-23-044036 | 001-40881 | 231195353 | 34 | 246745 | 1 | 1 |
| 2023-08-16 | UPLOAD | filename1.pdf | 0000000000-23-008916 | 43203 | ||||||
| 2023-08-11 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-003168 | 001-40881 | 231164995 | 33 | 8809 | |||
| 2023-08-11 | 10-Q | 10-Q | 0000950170-23-041605 | 001-40881 | 231161530 | 34 | 8962059 | 1 | 1 | |
| 2023-08-11 | 425 | 425 | 0000950170-23-041602 | 333029 | ||||||
| 2023-08-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-041601 | 001-40881 | 231161512 | 34 | 462223 | 1 | 1 |
| 2023-08-11 | 425 | 425 | 0000950170-23-041579 | 1078206 | ||||||
| 2023-08-11 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-041578 | 001-40881 | 231161441 | 34 | 1237018 | 1 | 1 |
| 2023-08-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002778 | 001-40881 | 231132762 | 33 | 8767 | |||
| 2023-07-31 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002717 | 001-40881 | 231127913 | 33 | 7660 | |||
| 2023-07-28 | 144/A | xsl144X01/primary_doc.xml | 0001959173-23-002663 | 001-40881 | 231120672 | 33 | 7295 | |||
| 2023-07-27 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002659 | 001-40881 | 231119288 | 33 | 8684 | |||
| 2023-07-21 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002566 | 001-40881 | 231102807 | 33 | 6495 | |||
| 2023-07-11 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002338 | 001-40881 | 231081779 | 33 | 5898 | |||
| 2023-06-30 | EFFECT | xslEFFECTX01/primary_doc.xml | S-4,,2023-06-30 15:00:00 | 9999999995-23-001957 | 333-272510 | 231063443 | 33 | 1658 | ||
| 2023-06-30 | 425 | 425 | 0000950170-23-031134 | 60800 | ||||||
| 2023-06-30 | 8-K | 8-K | 5.02 | 0000950170-23-031128 | 001-40881 | 231062186 | 34 | 191615 | 1 | 1 |
| 2023-06-30 | 424B3 | FORM 424B3 | 0001437749-23-019027 | 333-272510 | 231061690 | 33 | 5218722 | |||
| 2023-06-29 | CORRESP | filename1.htm | 0001437749-23-018918 | 8794 | ||||||
| 2023-06-29 | S-4/A | FORM S-4/A | 0001437749-23-018898 | 333-272510 | 231057468 | 33 | 17545514 | 1 | 1 | |
| 2023-06-16 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-001971 | 001-40881 | 231020701 | 33 | 5308 | |||
| 2023-06-15 | UPLOAD | filename1.pdf | 0000000000-23-006475 | 40125 | ||||||
| 2023-06-13 | 8-K | 8-K | 5.07 | 0000950170-23-027742 | 001-40881 | 231011954 | 34 | 203794 | 1 | 1 |
| 2023-06-08 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-001717 | 001-40881 | 231001834 | 33 | 5286 | |||
| 2023-06-08 | S-4 | FORM S-4 | 0001437749-23-016930 | 333-272510 | 231000758 | 33 | 17616863 | 1 | 1 | |
| 2023-06-07 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-001686 | 001-40881 | 231000314 | 33 | 4693 | |||
| 2023-05-30 | 425 | 425 | 0000950170-23-024900 | 001-40881 | 23977142 | 34 | 49635 | |||
| 2023-05-25 | 425 | 425 | 0000950170-23-024070 | 142437 | ||||||
| 2023-05-24 | 425 | 425 | 0000950170-23-023958 | 24551 | ||||||
| 2023-05-24 | 425 | 425 | 0000950170-23-023950 | 19089138 | ||||||
| 2023-05-24 | 8-K | 8-K | 7.01,9.01 | 0000950170-23-023946 | 001-40881 | 23954878 | 34 | 19237297 | 1 | 1 |
| 2023-05-24 | 425 | 425 | 0001193125-23-152390 | 001-40881 | 23950578 | 34 | 636484 | |||
| 2023-05-24 | 425 | 425 | 0000950170-23-023756 | 001-40881 | 23950573 | 34 | 1606775 | |||
| 2023-05-24 | 8-K | 8-K | 1.01,5.02,7.01,8.01,9.01 | 0000950170-23-023753 | 001-40881 | 23950557 | 34 | 1908420 | 1 | 1 |
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-020836 | 001-40881 | 23908809 | 34 | 7715446 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-020833 | 001-40881 | 23908799 | 34 | 397337 | 1 | 1 |
| 2023-05-10 | 10-K/A | 10-K/A | 0000950170-23-020611 | 001-40881 | 23907129 | 34 | 2023853 | 1 | 1 | |
| 2023-04-28 | ARS | ARS | 0000950170-23-015881 | 001-40881 | 23867131 | 34 | 15005133 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0000950170-23-015869 | 001-40881 | 23866952 | 34 | 263074 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0000950170-23-015858 | 001-40881 | 23866885 | 34 | 1629175 | |||
| 2023-04-04 | SC 13D/A | SC 13D/A | 0000950170-23-011796 | 005-92951 | 23798904 | 34 | 79454 | |||
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-021415 | 14893 | ||||||
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-021413 | 14882 | ||||||
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-021412 | 14943 | ||||||
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-021411 | 12020 | ||||||
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-021409 | 4781 | ||||||
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-021408 | 4781 | ||||||
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-021407 | 4758 | ||||||
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-021405 | 4724 | ||||||
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-021404 | 5671 | ||||||
| 2023-03-28 | 8-K | 8-K | 5.02 | 0000950170-23-010318 | 001-40881 | 23770044 | 34 | 185755 | 1 | 1 |
| 2023-03-23 | SC 13G/A | SC 13G A 2 PYXIS ONCOLOGY | 0000078003-23-000053 | 005-92951 | 23756501 | 34 | 76962 | |||
| 2023-03-23 | 4/A | PRIMARY DOCUMENT | 0000078003-23-000052 | 7266 | ||||||
| 2023-03-22 | S-8 | S-8 | 0000950170-23-009209 | 333-270753 | 23753404 | 33 | 258176 | |||
| 2023-03-22 | 10-K | 10-K | 0000950170-23-009046 | 001-40881 | 23751286 | 34 | 18143477 | 1 | 1 | |
| 2023-03-22 | 8-K | 8-K | 2.02,5.02 | 0000950170-23-009044 | 001-40881 | 23751253 | 34 | 414601 | 1 | 1 |
| 2023-03-21 | 4 | PRIMARY DOCUMENT | 0000078003-23-000050 | 7059 | ||||||
| 2023-03-16 | 8-K | 8-K | 7.01,9.01 | 0000950170-23-008307 | 001-40881 | 23737167 | 34 | 218310 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021802 | 005-92951 | 23630730 | 34 | 86071 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-23-002402 | 005-92951 | 23628410 | 34 | 82257 | |||
| 2023-02-14 | SC 13G/A | PYXIS ONCOLOGY, INC. | 0000902664-23-001702 | 005-92951 | 23623767 | 34 | 61762 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-23-000475 | 005-92951 | 23620646 | 34 | 276614 | |||
| 2023-02-13 | SC 13G/A | SC 13G/A PYXIS ONCOLOGY | 0000078003-23-000013 | 005-92951 | 23619902 | 34 | 74352 | |||
| 2023-02-08 | SC 13G | laurion-pyxs123122.htm | 0001172661-23-000538 | 005-92951 | 23600086 | 34 | 101105 | |||
| 2023-01-03 | 4 | FORM 4 | 0001567619-23-000068 | 4704 | ||||||
| 2023-01-03 | 4 | FORM 4 | 0001567619-23-000067 | 4679 | ||||||
| 2023-01-03 | 4 | FORM 4 | 0001567619-23-000066 | 4635 | ||||||
| 2022-12-01 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-025912 | 001-40881 | 221437284 | 34 | 219213 | 1 | 1 |
| 2022-11-14 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-11-14 16:00:00 | 9999999995-22-003295 | 333-268100 | 221389186 | 33 | 1672 | ||
| 2022-11-10 | CORRESP | filename1.htm | 0001193125-22-282411 | 6557 | ||||||
| 2022-11-04 | SC 13G | p111223sc13g.htm | 0001214659-22-013148 | 005-92951 | 221362218 | 34 | 90688 | |||
| 2022-11-03 | UPLOAD | filename1.pdf | 0000000000-22-011981 | 40081 | ||||||
| 2022-11-01 | S-3 | S-3 | 0001193125-22-275013 | 333-268100 | 221351170 | 33 | 1057005 | |||
| 2022-11-01 | 10-Q | 10-Q | 0000950170-22-020701 | 001-40881 | 221348506 | 34 | 9149954 | 1 | 1 | |
| 2022-11-01 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-020699 | 001-40881 | 221348480 | 34 | 453388 | 1 | 1 |
| 2022-10-13 | 3 | PRIMARY DOCUMENT | 0000078003-22-000095 | 6044 | ||||||
| 2022-10-07 | 8-K | 8-K | 1.01,3.02 | 0001193125-22-259636 | 001-40881 | 221301088 | 34 | 146637 | 1 | 1 |
| 2022-08-15 | 4 | FORM 4 | 0001140361-22-029677 | 4968 | ||||||
| 2022-08-15 | 3 | FORM 3 | 0001140361-22-029665 | 11906 | ||||||
| 2022-08-15 | 10-Q | 10-Q | 0000950170-22-017222 | 001-40881 | 221162304 | 34 | 7531900 | 1 | 1 | |
| 2022-08-15 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-22-017220 | 001-40881 | 221162294 | 34 | 444709 | 1 | 1 |
| 2022-08-09 | 3 | FORM 3 | 0001567619-22-015316 | 15157 | ||||||
| 2022-08-09 | 8-K | 8-K | 5.02 | 0000950170-22-016063 | 001-40881 | 221148448 | 34 | 170474 | 1 | 1 |
| 2022-07-01 | S-8 | S-8 | 0001193125-22-187297 | 333-266005 | 221062247 | 33 | 86278 | |||
| 2022-06-14 | 8-K | 8-K | 5.07 | 0001193125-22-173861 | 001-40881 | 221015232 | 34 | 149401 | 1 | 1 |
| 2022-05-23 | SC 13D/A | SC 13D/A | 0001140361-22-020157 | 005-92951 | 22949531 | 34 | 48949 | |||
| 2022-05-13 | 10-Q | 10-Q | 0000950170-22-009807 | 001-40881 | 22920340 | 34 | 6874516 | 1 | 1 | |
| 2022-05-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-009803 | 001-40881 | 22920324 | 34 | 352977 | 1 | 1 |
| 2022-04-28 | DEFA14A | DEFA14A | 0001193125-22-127730 | 001-40881 | 22867303 | 34 | 530158 | |||
| 2022-04-28 | DEF 14A | DEF 14A | 0001193125-22-127710 | 001-40881 | 22867239 | 34 | 1418761 | |||
| 2022-04-27 | 4 | PRIMARY DOCUMENT | 0000312069-22-000068 | 3996 | ||||||
| 2022-04-26 | 3 | PRIMARY DOCUMENT | 0000312069-22-000067 | 5364 | ||||||
| 2022-04-25 | 4 | FORM 4 SUBMISSION | 0000899243-22-015542 | 5043 | ||||||
| 2022-04-15 | 4 | FORM 4 | 0001567619-22-008615 | 4983 | ||||||
| 2022-04-15 | 4 | FORM 4 | 0001567619-22-008614 | 5028 | ||||||
| 2022-04-15 | 4 | FORM 4 | 0001567619-22-008613 | 5359 | ||||||
| 2022-04-14 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-22-105729 | 001-40881 | 22828173 | 34 | 176705 | 1 | 1 |
| 2022-04-04 | 4 | FORM 4 | 0001140361-22-012921 | 4351 | ||||||
| 2022-04-04 | 4 | FORM 4 | 0001140361-22-012918 | 4540 | ||||||
| 2022-04-04 | 4 | FORM 4 | 0001140361-22-012924 | 4607 | ||||||
| 2022-04-04 | 4 | FORM 4 | 0001140361-22-012919 | 5263 | ||||||
| 2022-04-04 | 4 | FORM 4 | 0001140361-22-012917 | 5534 | ||||||
| 2022-04-04 | 4 | FORM 4 | 0001140361-22-012914 | 4316 | ||||||
| 2022-04-04 | 4 | FORM 4 | 0001140361-22-012916 | 4496 | ||||||
| 2022-04-04 | 4 | FORM 4 | 0001140361-22-012913 | 4373 | ||||||
| 2022-03-29 | S-8 | S-8 | 0001193125-22-088207 | 333-263950 | 22781614 | 33 | 66406 | |||
| 2022-03-29 | 10-K | 10-K | 0000950170-22-004850 | 001-40881 | 22777379 | 34 | 18726451 | 1 | 1 | |
| 2022-03-29 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-22-004848 | 001-40881 | 22777372 | 34 | 375385 | 1 | 1 |
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-022766 | 005-92951 | 22631947 | 34 | 86530 | |||
| 2022-02-14 | SC 13G | PYXIS ONCOLOGY, INC. | 0000902664-22-001604 | 005-92951 | 22625776 | 34 | 66250 | |||
| 2022-02-11 | SC 13G | SC 13G | 0001104659-22-020578 | 005-92951 | 22621766 | 34 | 63060 | |||
| 2022-02-11 | SC 13G | SC 13G PYXIS ONCOLOGY | 0000078003-22-000010 | 005-92951 | 22621511 | 34 | 76714 | |||
| 2021-12-20 | SC 13G | THE SCHEDULE 13G | 0000921895-21-002880 | 005-92951 | 211506150 | 34 | 285450 | |||
| 2021-12-09 | 4 | FORM 4 SUBMISSION | 0000899243-21-047525 | 4954 | ||||||
| 2021-12-07 | 4 | FORM 4 SUBMISSION | 0000899243-21-047102 | 5364 | ||||||
| 2021-11-19 | 4 | FORM 4 SUBMISSION | 0000899243-21-045363 | 5332 | ||||||
| 2021-11-15 | 10-Q | 10-Q | 0000950170-21-004476 | 001-40881 | 211406399 | 34 | 8235816 | 1 | 1 | |
| 2021-11-15 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-004462 | 001-40881 | 211406364 | 34 | 409903 | 1 | 1 |
| 2021-10-25 | SC 13G | SC 13G | 0001104659-21-129526 | 005-92951 | 211344526 | 34 | 80578 | |||
| 2021-10-22 | S-8 | S-8 | 0001193125-21-305462 | 333-260441 | 211340820 | 33 | 352681 | |||
| 2021-10-22 | SC 13D | efc21-572_sc13d.htm | 0000905148-21-000683 | 005-92951 | 211338225 | 34 | 59054 | |||
| 2021-10-15 | 4 | FORM 4 | 0001140361-21-034645 | 8947 | ||||||
| 2021-10-15 | 4 | FORM 4 | 0001140361-21-034643 | 6868 | ||||||
| 2021-10-15 | 4 | PRIMARY DOCUMENT | 0001578563-21-000038 | 11648 | ||||||
| 2021-10-15 | 4 | FORM 4 | 0001567619-21-018355 | 15900 | ||||||
| 2021-10-12 | 4 | FORM 4 | 0001140361-21-034427 | 5059 | ||||||
| 2021-10-12 | 4 | FORM 4 | 0001140361-21-034426 | 5063 | ||||||
| 2021-10-12 | 4 | FORM 4 | 0001140361-21-034425 | 5029 | ||||||
| 2021-10-12 | 4 | FORM 4 | 0001140361-21-034424 | 6849 | ||||||
| 2021-10-12 | 4 | FORM 4 | 0001140361-21-034423 | 5016 | ||||||
| 2021-10-12 | 4 | FORM 4 | 0001140361-21-034422 | 5086 | ||||||
| 2021-10-12 | 4 | FORM 4 | 0001140361-21-034421 | 5305 | ||||||
| 2021-10-12 | 4 | FORM 4 | 0001140361-21-034420 | 5072 | ||||||
| 2021-10-12 | 4 | FORM 4 | 0001140361-21-034419 | 5063 | ||||||
| 2021-10-08 | 424B4 | 424B4 | 0001193125-21-295600 | 333-259627 | 211315906 | 33 | 6186228 | |||
| 2021-10-07 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-10-07 16:00:00 | 9999999995-21-003820 | 333-259627 | 211313738 | 33 | 1706 | ||
| 2021-10-07 | S-1MEF | S-1MEF | 0001193125-21-294497 | 333-260127 | 211313721 | 33 | 54877 | |||
| 2021-10-07 | 3 | FORM 3 | 0001140361-21-034083 | 16469 | ||||||
| 2021-10-07 | 3 | FORM 3 | 0001140361-21-034081 | 15395 | ||||||
| 2021-10-07 | 3 | FORM 3 | 0001140361-21-034079 | 16466 | ||||||
| 2021-10-07 | 3 | FORM 3 | 0001140361-21-034077 | 16327 | ||||||
| 2021-10-07 | 3 | PRIMARY DOCUMENT | 0001578563-21-000036 | 8202 | ||||||
| 2021-10-07 | 3 | FORM 3 | 0001140361-21-034075 | 15492 | ||||||
| 2021-10-07 | 3 | FORM 3 | 0001140361-21-034072 | 14077 | ||||||
| 2021-10-07 | 3 | FORM 3 | 0001140361-21-034070 | 15359 | ||||||
| 2021-10-07 | 3 | FORM 3 | 0001140361-21-034068 | 14144 | ||||||
| 2021-10-07 | 3 | FORM 3 | 0001140361-21-034066 | 14097 | ||||||
| 2021-10-07 | 3 | FORM 3 | 0001140361-21-034063 | 16104 | ||||||
| 2021-10-07 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-005189 | 394706 | ||||||
| 2021-10-07 | 3 | FORM 3 | 0001567619-21-018043 | 11327 | ||||||
| 2021-10-07 | S-1/A | S-1/A | 0001193125-21-293655 | 333-259627 | 211311009 | 33 | 6291962 | |||
| 2021-10-06 | CERT | 8A_CERT_PYXS.pdf | 0001354457-21-001130 | 001-40881 | 211309072 | 34 | 250042 | |||
| 2021-10-05 | 8-A12B | 8-A12B | 0001193125-21-292187 | 001-40881 | 211307366 | 34 | 13321 | |||
| 2021-10-05 | CORRESP | filename1.htm | 0001193125-21-292066 | 14487 | ||||||
| 2021-10-05 | CORRESP | filename1.htm | 0001193125-21-292052 | 8723 | ||||||
| 2021-10-04 | S-1/A | S-1/A | 0001193125-21-290298 | 333-259627 | 211300943 | 33 | 7676412 | |||
| 2021-10-01 | S-1/A | S-1/A | 0001193125-21-288350 | 333-259627 | 211296627 | 33 | 1253852 | |||
| 2021-09-28 | CORRESP | filename1.htm | 0001193125-21-285776 | 92196 | ||||||
| 2021-09-17 | S-1 | S-1 | 0001193125-21-276227 | 333-259627 | 211261130 | 33 | 7088109 | |||
| 2021-09-17 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004807 | 400469 | ||||||
| 2021-09-10 | DRS/A | filename1.htm | 0000950123-21-012245 | 377-05065 | 211245712 | 33 | 7046199 | |||
| 2021-09-09 | DRSLTR | filename1.htm | 0000950123-21-012246 | 17774 | ||||||
| 2021-08-18 | UPLOAD | filename1.pdf | 0000000000-21-010164 | 44665 | ||||||
| 2021-08-04 | DRSLTR | filename1.htm | 0000950123-21-009657 | 39383 | ||||||
| 2021-08-04 | DRS/A | filename1.htm | 0000950123-21-009656 | 377-05065 | 211145184 | 33 | 6149819 | |||
| 2021-07-16 | UPLOAD | filename1.pdf | 0000000000-21-008827 | 57774 | ||||||
| 2021-06-21 | DRS | filename1.htm | 0000950123-21-008029 | 377-05065 | 211031385 | 33 | 5742171 | |||
| 2021-03-22 | D | xslFormDX01/primary_doc.xml | 06b | 0001782223-21-000002 | 021-393076 | 21761959 | 33 | 11187 | ||
| 2019-07-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001782223-19-000001 | 021-344177 | 19952811 | 33 | 10067 |
One latest value per concept from companyfacts (267 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 119.61M | 2026-11-04 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 64.40M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 17,756.48 | 2026-08-20 | S-3 | 2026-08-20 | 0001193125-26-359246 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 17,756.48 | 2026-08-20 | S-3 | 2026-08-20 | 0001193125-26-359246 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 128.58M | 2026-08-20 | S-3 | 2026-08-20 | 0001193125-26-359246 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-20 | S-3 | 2026-08-20 | 0001193125-26-359246 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-20 | S-3 | 2026-08-20 | 0001193125-26-359246 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 8.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 3.00M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0000950170-25-108906 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 771,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 9.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 810,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 7.01M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -56,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 553.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 8.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 8.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 39.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | AreaOfRealEstateProperty | Area of Real Estate Property | sqft | 17,729 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | Assets | Assets | USD | 76.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 59.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-01 | 0000950170-22-020701 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 53,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 56,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 51.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 51.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | BusinessCombinationAcquisitionRelatedCosts | Business Combination, Acquisition Related Costs | USD | 1.30M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060354 |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | USD | 31.64M | 2023-08-23 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents | USD | 6.66M | 2023-08-23 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets | USD | 519,000 | 2023-08-23 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable | USD | 4.55M | 2023-08-23 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue | USD | 6.66M | 2023-08-23 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities | USD | 2.16M | 2023-08-23 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill | USD | 24.46M | 2023-08-23 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities | USD | 20.91M | 2023-08-23 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | USD | 10.73M | 2023-08-23 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 237,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 |
| us-gaap | CapitalUnitsAuthorized | Capital Units, Authorized | shares | 200.00M | 2021-10-08 | 2021 | FY | 10-K | 2022-03-29 | 0000950170-22-004850 | |
| us-gaap | CashAcquiredFromAcquisition | Cash Acquired from Acquisition | USD | 6.66M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 3.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 55.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 5.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 5.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -11.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 42.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 190.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 83.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 83.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 83,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -68.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 7.66M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 2.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 300,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 1.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 53,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 8,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 41.70M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 3.50M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004476 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 3.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 1.10M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004476 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 2.03M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | DeferredTaxAssetsDerivativeInstruments | Deferred Tax Assets, Derivative Instruments | USD | 1.07M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 49,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 154.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 2.16M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034868 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 3.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 96.34M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 276,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 12.87M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 3.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 796,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 151.59M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | Depreciation | Depreciation | USD | 1.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | -6.23M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009046 |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 9.12M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004476 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 67,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004476 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.98 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.97 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0000950170-22-009807 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.98 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.205 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.024 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.024 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.017 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 3.32M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 12.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | FederalIncomeTaxExpenseBenefitContinuingOperations | Federal Income Tax Expense (Benefit), Continuing Operations | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 514,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 1.49M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 223,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 223,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 223,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 223,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 223,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 2.60M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040771 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 18.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -68.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009046 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 48,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034868 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 1.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 46,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 16.01M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -16.42M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | -169,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.89M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 42,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 1.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -2.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347913 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 1.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -7.66M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncreaseDecreaseInDeferredLiabilities | Increase (Decrease) in Deferred Liabilities | USD | -2.16M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | IncreaseDecreaseInDerivativeLiabilities | Increase (Decrease) in Derivative Liabilities | USD | 3.37M | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-01 | 0000950170-22-020701 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 340,000 | 2022-01-01 | 2022-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-020836 |
| us-gaap | IncreaseDecreaseInOtherOperatingCapitalNet | Increase (Decrease) in Other Operating Assets and Liabilities, Net | USD | 23,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -1.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | IntangibleAssetsGrossExcludingGoodwill | Intangible Assets, Gross (Excluding Goodwill) | USD | 2.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | IntangibleAssetsNetIncludingGoodwill | Intangible Assets, Net (Including Goodwill) | USD | 0 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034868 | |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 91,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 21,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034868 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 480,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 1.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 771,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | LeaseCost | Lease, Cost | USD | 2.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 25.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 7.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 3.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 3.79M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 3.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 3.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 3.47M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 1.50M | 2023-02-02 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060354 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 7.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | Liabilities | Liabilities | USD | 35.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 76.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 19.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-01 | 0000950170-22-020701 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 51.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -109,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 48.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 380,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -60.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -68.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 2.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-124602 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 70.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -70.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 714,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 18.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 15.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 2.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 10.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 700,000 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-020836 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.094 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 431,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 626,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 109,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009046 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -109,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 2.45M | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-01 | 0000950170-22-020701 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 113,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 63.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | PaymentsToAcquireInterestInJointVenture | Payments to Acquire Interest in Joint Venture | USD | 50,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009046 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.78M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 2.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 586,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 152.30M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009046 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 3,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-29 | 0000950170-22-004850 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 151.58M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009046 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 48.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 322,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -68.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 15.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 6.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 52.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 20.00M | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-01 | 0000950170-22-020701 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 1.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 1.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings | Restricted Stock, Shares Issued Net of Shares for Tax Withholdings | shares | 2.94M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0000950170-22-017222 |
| us-gaap | RestrictedStockValueSharesIssuedNetOfTaxWithholdings | Restricted Stock, Value, Shares Issued Net of Tax Withholdings | USD | -35,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -511.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | Revenues | Revenues | USD | 13.86M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 265,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 14.50M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034868 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 400,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034868 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 8.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 117,849 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 0.12 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 143,708 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 968,512 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 2.83 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 196,164 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0000950170-22-017222 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 0.05 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0000950170-22-017222 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.997 | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347913 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 1.03 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.971 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.041 | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347913 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.046 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.039 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 5.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 11.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 4.23 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 400,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 8,668 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 445,435 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 6.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.91 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 9.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 18.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 3.54 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 5,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-29 | 0000950170-22-004850 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.56 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 1.62 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 2.17 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 2.47 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 21,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | StateAndLocalIncomeTaxExpenseBenefitContinuingOperations | State and Local Income Tax Expense (Benefit), Continuing Operations | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001193125-26-222843 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 41.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.157 | 2021-10-01 | 2021 | FY | 10-K | 2022-03-29 | 0000950170-22-004850 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 206,384 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 194.02M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009046 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 108,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 48.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | -393,000 | 2023-07-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-124602 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 322,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 1.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | UnrealizedGainLossOnDerivatives | Unrealized Gain (Loss) on Derivatives | USD | -6.23M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009046 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 2.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued | Unrecognized Tax Benefits, Income Tax Penalties Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued | Unrecognized Tax Benefits, Interest on Income Taxes Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 11.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-118532 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 910,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 70.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 32.32M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0000950170-22-009807 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 70.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448612 |